Literature DB >> 33710629

Prescriber perspectives on low-value prescribing: A qualitative study.

Eric L Walter1, Alicia Dawdani2, Alison Decker2, Megan E Hamm2, Aimee N Pickering2, Joseph T Hanlon3,4,5, Carolyn T Thorpe6,7, Mark S Roberts2,8, Michael J Fine2,7, Walid F Gellad2,4,7, Thomas R Radomski2,4,7.   

Abstract

BACKGROUND: Health systems are increasingly implementing interventions to reduce older patients' use of low-value medications. However, prescribers' perspectives on medication value and the acceptability of interventions to reduce low-value prescribing are poorly understood.
OBJECTIVE: To identify the characteristics that affect the value of a medication and those factors influencing low-value prescribing from the perspective of primary care physicians.
DESIGN: Qualitative study using semi-structured interviews.
SETTING: Academic and community primary care practices within University of Pittsburgh Medical Center health system. PARTICIPANTS: Sixteen primary care physicians. MEASUREMENTS: We elicited 16 prescribers' perspectives on definitions and examples of low-value prescribing in older adults, the factors that incentivize them to engage in such prescribing, and the characteristics of interventions that would make them less likely to engage in low-value prescribing.
RESULTS: We identified three key themes. First, prescribers viewed low-value prescribing among older adults as common, characterized both by features of the medications themselves and of the particular patients to whom they were prescribed. Second, prescribers described the causes of low-value prescribing as multifactorial, with factors related to patients, prescribers, and the health system as a whole, making low-value prescribing a default practice pattern. Third, interventions addressing low-value prescribing must minimize the cognitive load and time pressures that make low-value prescribing common. Interventions increasing time pressure or cognitive load, such as increased documentation, were considered less acceptable.
CONCLUSIONS: Our findings demonstrate that low-value prescribing is a well-recognized phenomenon, and that interventions to reduce low-value prescribing must consider physicians' perspectives and address the specific patient, prescriber and health system factors that make low-value prescribing a default practice.
© 2021 The American Geriatrics Society.

Entities:  

Keywords:  deprescribing; low-value care; medication value; polypharmacy

Mesh:

Year:  2021        PMID: 33710629      PMCID: PMC8192466          DOI: 10.1111/jgs.17099

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   7.538


  19 in total

Review 1.  A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.

Authors:  Emily Reeve; Danijela Gnjidic; Janet Long; Sarah Hilmer
Journal:  Br J Clin Pharmacol       Date:  2015-12       Impact factor: 4.335

Review 2.  Clinical consequences of polypharmacy in elderly.

Authors:  Robert L Maher; Joseph Hanlon; Emily R Hajjar
Journal:  Expert Opin Drug Saf       Date:  2013-09-27       Impact factor: 4.250

3.  Attitudes of Older Adults and Caregivers in Australia toward Deprescribing.

Authors:  Emily Reeve; Lee-Fay Low; Sarah N Hilmer
Journal:  J Am Geriatr Soc       Date:  2019-02-13       Impact factor: 5.562

4.  Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework.

Authors:  Amy Linsky; Walid F Gellad; Jeffrey A Linder; Mark W Friedberg
Journal:  J Am Geriatr Soc       Date:  2019-08-20       Impact factor: 5.562

5.  Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study.

Authors:  Aimee N Pickering; Megan E Hamm; Alicia Dawdani; Joseph T Hanlon; Carolyn T Thorpe; Walid F Gellad; Thomas R Radomski
Journal:  J Am Geriatr Soc       Date:  2020-02-17       Impact factor: 5.562

6.  Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study.

Authors:  Jan Schuling; Henkjan Gebben; Leonardus Johannes Gerardus Veehof; Flora Marcia Haaijer-Ruskamp
Journal:  BMC Fam Pract       Date:  2012-07-09       Impact factor: 2.497

7.  Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study.

Authors:  Teresa Pérez; Frank Moriarty; Emma Wallace; Ronald McDowell; Patrick Redmond; Tom Fahey
Journal:  BMJ       Date:  2018-11-14

8.  "The ultimate decision is yours": exploring patients' attitudes about the overuse of medical interventions.

Authors:  David Schleifer; David J Rothman
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

Review 9.  Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis.

Authors:  Kristen Anderson; Danielle Stowasser; Christopher Freeman; Ian Scott
Journal:  BMJ Open       Date:  2014-12-08       Impact factor: 2.692

10.  A survey of primary care patients' readiness to engage in the de-adoption practices recommended by Choosing Wisely Canada.

Authors:  William Silverstein; Elliot Lass; Karen Born; Anne Morinville; Wendy Levinson; Cara Tannenbaum
Journal:  BMC Res Notes       Date:  2016-06-10
View more
  3 in total

1.  Re: Negative treatments… changing our words to drive deprescribing.

Authors:  Thomas R Radomski
Journal:  J Am Geriatr Soc       Date:  2021-09-15       Impact factor: 5.562

2.  Primary care physicians' approaches to low-value prescribing in older adults: a qualitative study.

Authors:  Aimee N Pickering; Eric L Walter; Alicia Dawdani; Alison Decker; Megan E Hamm; Walid F Gellad; Thomas R Radomski
Journal:  BMC Geriatr       Date:  2022-02-24       Impact factor: 3.921

3.  Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults.

Authors:  Thomas R Radomski; Alison Decker; Dmitry Khodyakov; Carolyn T Thorpe; Joseph T Hanlon; Mark S Roberts; Michael J Fine; Walid F Gellad
Journal:  JAMA Netw Open       Date:  2022-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.